BXP, Inc.
No SEC Form 4 filings for $BXP in the last 30 days.
See all $BXP insider activity →Evercore ISI reduced its price target for BXP from $67 to $65, maintaining an 'In Line' rating. JPMorgan also adjusted its target for BXP, lowering it from $87 to $81 while keeping an 'Overweight' rating. BXP's stock has declined 4.90% year-to-date and 12.02% over 5 days.
JPMorgan lowered its price target on BXP from $87 to $81, while maintaining an 'overweight' rating. The stock has seen a 5-day change of -1.37%, a 1st Jan change of -4.66%, and a year-to-date change of -11.79%.
Global stock markets fell on Thursday due to bond yield volatility, with the S&P 500 down 0.3% and European markets seeing sharper declines. Rising yields, driven by inflation concerns and strong U.S. economic data, are increasing borrowing costs and pressuring investments. Oil prices also climbed, adding to inflation pressures. Micron Technology's strong earnings report boosted some AI-related stocks, while real-estate stocks declined.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning BXP (BXP, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.
Recent BXP coverage spans financial news, corporate actions and sector analysis.
Analyst price‑target cut suggests potential downside pressure on the stock.
Analyst target cut suggests lower near‑term upside.
Rising yields increase borrowing costs, weighing on REIT valuations.
The extension improves the project's financing prospects but depends on securing a major tenant.
Analyst downgrade may pressure the stock lower in the short term.
AlphAI scores every news story that mentions BXP with an AI model for sentiment and relevance, and aggregates insider trades from BXP, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Evercore ISI reduced its price target for BXP from $67 to $65, maintaining an 'In Line' rating. JPMorgan also adjusted its target for BXP, lowering it from $87 to $81 while keeping an 'Overweight' rating. BXP's stock has declined 4.90% year-to-date and 12.02% over 5 days.
1 min readJPMorgan lowered its price target on BXP from $87 to $81, while maintaining an 'overweight' rating. The stock has seen a 5-day change of -1.37%, a 1st Jan change of -4.66%, and a year-to-date change of -11.79%.
1 min readGlobal stock markets fell on Thursday due to bond yield volatility, with the S&P 500 down 0.3% and European markets seeing sharper declines. Rising yields, driven by inflation concerns and strong U.S. economic data, are increasing borrowing costs and pressuring investments. Oil prices also climbed, adding to inflation pressures. Micron Technology's strong earnings report boosted some AI-related stocks, while real-estate stocks declined.
3 min readBXP, formerly Boston Properties, received an 18-month extension for its $1B office development at 725 Harrison Street in San Francisco. The project, initially announced in 2015, includes 770,000 sq ft of office space and 36,000 sq ft of retail. BXP needs a major tenant to secure financing, citing high construction costs and interest rates. The company points to a surge in office leasing, particularly from AI companies, as a positive sign.
2 min readEvercore ISI reduced its price target for BXP from $71 to $67, maintaining an 'In Line' rating. Scotiabank also lowered its target from $76 to $73, keeping a 'Sector Outperform' rating. BXP's stock price was $63.17, down 1.19%.
1 min readBXP Inc. announced it will maintain its quarterly dividend at $0.70 per share, payable on October 30 to shareholders of record on September 30. The company's stock has seen a 5-day change of +0.31%, a 1st Jan change of -0.39%, and a year-to-date change of -5.10%.
1 min readBeximco Pharmaceuticals PLC clarifies press reports suggesting Salman F Rahman may resign as Vice-Chairman. The company is in discussions with BSEC about potential board changes, subject to final agreement and due diligence. The matter is tied to ongoing legal cases in Bangladesh's High Court.
1 min readU.S. real estate stocks declined as investors increased expectations for a September Fed rate hike to 55%, up from 35.4%. The S&P 500 Real Estate sector fell 1.28%, while XLRE dropped 1.33% to $44.48. Host Hotels & Resorts (HST) and Iron Mountain (IRM) led large-cap decliners, while SBA Communications (SBAC) gained 4.58%. Fermi (FRMI) and Real REMAX Group (REAX) were among the notable mid and small-cap losers.
3 min readVieron Capital acquired a 210K SF office complex in D.C. from BXP for $66.8M, financed partly by a $31M loan from Bank of America. BXP recorded a $35M impairment charge on the sale. BXP is also selling another D.C. property and developing new office projects. Other D.C. real estate deals included leases and sales involving Jemal Equities, In-Rel Properties, and Douglas Development Corp.
2 min readBXP reported Q2 2026 earnings exceeding expectations and raised its full-year FFO outlook, citing improved business fundamentals. The company's investment narrative hinges on high-quality office and life science space in key markets, with risks tied to new developments and leasing. BXP's $1.2B construction loan for 343 Madison Avenue highlights both potential and risks. Analysts' earnings estimates for 2029 range from $290.1M to $343.6M, with revenue projections between $3.7B and $3.8B.
2 min read
